Hamilton-Based Startup Recognized for Groundbreaking AI Innovation in Early Cancer Detection...
Strategic Partnership to Advance Early Disease Detection with Cutting-Edge Optical Technology...
Next-generation closed-loop DBS device now approved in Europe, offering real-time, personalized neuromodulation for Parkinson’s and other neurological disorders....
New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025....
Joining NVIDIA’s Healthcare & Life Sciences ecosystem, Noul showcases miLab™ CER—its on-device, cloud-free solution tackling diagnostic gaps in cervical cancer and beyond....
With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...
Next-generation therapy integrates neuromodulation with spinal fusion to improve outcomes and reduce opioid reliance for over 500,000 spinal surgery patients annually in the U.S....
Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development....
Strategic Agreement Brings Evidence-Based Clinical Pathways to Radiation Oncology Workflows, Improving Care Quality and Efficiency ...
Innovative Spinal Rod Technology Enhances Surgical Flexibility and Patient-Specific Customization ...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
